These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16203870)

  • 1. Eplerenone inhibits atherosclerosis in nonhuman primates.
    Takai S; Jin D; Muramatsu M; Kirimura K; Sakonjo H; Miyazaki M
    Hypertension; 2005 Nov; 46(5):1135-9. PubMed ID: 16203870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regressive effect of an angiotensin II receptor blocker on formed fatty streaks in monkeys fed a high-cholesterol diet.
    Takai S; Jin D; Sakaguchi M; Muramatsu M; Miyazaki M
    J Hypertens; 2005 Oct; 23(10):1879-86. PubMed ID: 16148612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of eplerenone to an angiotensin-converting enzyme inhibitor effectively improves nitric oxide bioavailability.
    Imanishi T; Ikejima H; Tsujioka H; Kuroi A; Kobayashi K; Muragaki Y; Mochizuki S; Goto M; Yoshida K; Akasaka T
    Hypertension; 2008 Mar; 51(3):734-41. PubMed ID: 18227404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of angiotensin II type 1 receptor blocker for anti-atherosclerotic effect in monkeys fed a high-cholesterol diet.
    Takai S; Kim S; Sakonjo H; Miyazaki M
    J Hypertens; 2003 Feb; 21(2):361-9. PubMed ID: 12569267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eplerenone with valsartan effectively reduces atherosclerotic lesion by attenuation of oxidative stress and inflammation.
    Suzuki J; Iwai M; Mogi M; Oshita A; Yoshii T; Higaki J; Horiuchi M
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):917-21. PubMed ID: 16424347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-atherosclerotic effects of an angiotensin converting enzyme inhibitor and an angiotensin II antagonist in Cynomolgus monkeys fed a high-cholesterol diet.
    Miyazaki M; Sakonjo H; Takai S
    Br J Pharmacol; 1999 Oct; 128(3):523-9. PubMed ID: 10516628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineralocorticoid receptor blockade inhibits accelerated atherosclerosis induced by a low sodium diet in apolipoprotein E-deficient mice.
    Raz-Pasteur A; Gamliel-Lazarovich A; Gantman A; Coleman R; Keidar S
    J Renin Angiotensin Aldosterone Syst; 2014 Sep; 15(3):228-35. PubMed ID: 23223089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
    Endemann DH; Touyz RM; Iglarz M; Savoia C; Schiffrin EL
    Hypertension; 2004 Jun; 43(6):1252-7. PubMed ID: 15117913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-diabetic atherosclerosis effect of Prunella vulgaris in db/db mice with type 2 diabetes.
    Hwang SM; Kim JS; Lee YJ; Yoon JJ; Lee SM; Kang DG; Lee HS
    Am J Chin Med; 2012; 40(5):937-51. PubMed ID: 22928826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of angiotensin converting enzyme and angiotensin II receptors in the atherosclerotic aorta of high-cholesterol fed Cynomolgus monkeys.
    Song K; Shiota N; Takai S; Takashima H; Iwasaki H; Kim S; Miyazaki M
    Atherosclerosis; 1998 May; 138(1):171-82. PubMed ID: 9678783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiatherosclerotic effect of alacepril, an angiotensin-converting enzyme inhibitor, in monkeys fed a high-cholesterol diet.
    Miyazaki M; Takai S
    Hypertens Res; 1999 Mar; 22(1):49-54. PubMed ID: 10221351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin converting enzyme inhibitors and atherosclerosis.
    Andersson RG; Jacobsson L; Persson K
    J Physiol Pharmacol; 1994 Mar; 45(1):13-25. PubMed ID: 8043902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mineralocorticoid receptor antagonism in experimental atherosclerosis.
    Rajagopalan S; Duquaine D; King S; Pitt B; Patel P
    Circulation; 2002 May; 105(18):2212-6. PubMed ID: 11994257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
    Crouse JR; Raichlen JS; Riley WA; Evans GW; Palmer MK; O'Leary DH; Grobbee DE; Bots ML;
    JAMA; 2007 Mar; 297(12):1344-53. PubMed ID: 17384434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of candesartan and amlodipine in a monkey atherosclerotic model.
    Takai S; Jin D; Sakaguchi M; Muramatsu M; Ishii K; Kirimura K; Sakonjo H; Miyazaki M
    Hypertens Res; 2004 Jul; 27(7):517-22. PubMed ID: 15302989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eplerenone does not attenuate diabetes-associated atherosclerosis.
    Koh PJ; Koitka A; Cooper ME; Allen TJ
    J Hypertens; 2009 Jul; 27(7):1431-8. PubMed ID: 19381106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats.
    Tada Y; Kitazato KT; Tamura T; Yagi K; Shimada K; Kinouchi T; Satomi J; Nagahiro S
    Hypertension; 2009 Sep; 54(3):552-7. PubMed ID: 19620512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholesterol-lowering independent regression and stabilization of atherosclerotic lesions by pravastatin and by antimonocyte chemoattractant protein-1 therapy in nonhuman primates.
    Kitamoto S; Nakano K; Hirouchi Y; Kohjimoto Y; Kitajima S; Usui M; Inoue S; Egashira K
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1522-8. PubMed ID: 15178560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cynanchum wilfordii ameliorates hypertension and endothelial dysfunction in rats fed with high fat/cholesterol diets.
    Choi DH; Lee YJ; Kim JS; Kang DG; Lee HS
    Immunopharmacol Immunotoxicol; 2012 Feb; 34(1):4-11. PubMed ID: 22176675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
    Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M
    Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.